Device / Technology News

RSS

Nightingale on Demand receives EMR certification from Infoway

Canada Health Infoway (Infoway) announced today that Nightingale on Demand, a software product developed by Nightingale Informatix Corporation, (Nightingale), is the first product in Canada to successfully achieve electronic medical record (EMR) certification.

23 Mar 2012

UI receives three grants to hasten discovery of new TB therapeutics

Forty-five years. That's how long it's been since the last drug - rifampin - hit the market to treat tuberculosis, an infection that affects nearly one third of the world's population and causes 1.8 million deaths annually. The University of Illinois at Chicago College of Pharmacy has received three new federally-funded grants to hasten the discovery of new therapeutic treatments.

23 Mar 2012

WCI technique uses MRS to detect oncometabolites

Researchers at Winship Cancer Institute have developed a technique for detecting an "oncometabolite", a chemical produced by some brain tumors' warped metabolism, via non-invasive imaging.

23 Mar 2012

Study uses Veridex CellSearch technology to capture CECs in MI patients

Veridex, LLC today announced the publication of a new, investigational study published this week in Science Translational Medicine that lays the foundation for research that may potentially result in a blood test to determine imminent risk of heart attack within high-risk populations.

22 Mar 2012

Video capture and other automated systems cut down medical errors

USC Marshall study finds video capture and other automated systems cut down medical errors and minimize the tendency to operate outside normal procedures.

22 Mar 2012

Computer program could help dementia patients manage their disease

Researchers at Weill Cornell Medical College have developed a computer program that has tracked the manner in which different forms of dementia spread within a human brain. They say their mathematic model can be used to predict where and approximately when an individual patient's brain will suffer from the spread, neuron to neuron, of "prion-like" toxic proteins -- a process they say underlies all forms of dementia.

22 Mar 2012

Supreme Court limits patents on diagnostic medical tests

The U.S. Supreme Court put new limits on the availability of patents for diagnostic medical tests, ruling in favor of the Mayo Clinic in a case that will shape the growing field of personalized health care.

22 Mar 2012

MRI screening could be cost effective for women with familial risk of breast cancer

Adding magnetic resonance imaging (MRI) to standard breast cancer screening approaches is expensive, though it could be cost effective for a group of women who may not have inherited the breast cancer susceptibility genes, but who have a familial risk of developing the disease.

22 Mar 2012

NeuroLogica's BodyTom CT scanner receives CE Mark

NeuroLogica Corporation announced today it has received CE Mark approval for its most recent product BodyTom, a portable, full body, multi-slice CT scanner.

22 Mar 2012

Tomosynthesis may be more beneficial in diagnosing knee OA than X-ray imaging

A recent study done by researchers at Boston University School of Medicine (BUSM) shows that tomosynthesis may be more beneficial in diagnosing knee osteoarthritis than X-ray imaging.

22 Mar 2012

Challenges in Salivary Diagnostics symposium to take place on March 22

On March 22, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, a symposium titled "Challenges in Salivary Diagnostics" will take place to discuss the issues with saliva collection and storage, proteomic analyses, and the growing interest and availability of commercial tests for salivary biomarkers.

22 Mar 2012

New method for in vivo study of unknown selenium metabolism

Spanish and Danish researchers have developed a method for the in vivo study of the unknown metabolism of selenium, an essential element for living beings. The technique can help clarify whether or not it possesses the anti-tumour properties that have been attributed to it and yet have not been verified through clinical trials.

22 Mar 2012

Peripheral nerve stimulation may help manage neuropathic pain in injured soldiers

An peripheral nerve stimulation technique may be a valuable new approach for relief of severe neuropathic (nerve-related) pain in injured soldiers, reports an article in the March issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

22 Mar 2012

TGA clears Bioline's illumigene Group B Streptococcus test

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., today announced that it has received clearance from the Therapeutic Goods Administration (TGA) for its illumigene Group B Streptococcus (GBS) test, the newest molecular product on the illumigene platform.

22 Mar 2012

USAID World TB Day website

USAID's website features a page dedicated to World TB Day, which will be commemorated on March 24. The page lists information on upcoming events, as well as links to several reports, such as the FY2010 Report to Congress on the Global TB Context, stories, and features.

21 Mar 2012

Scans reveal Williams syndrome-associated personality/temperament traits

A personality profile marked by overly gregarious yet anxious behavior is rooted in abnormal development of a circuit hub buried deep in the front center of the brain, say scientists at the National Institutes of Health. They used three different types of brain imaging to pinpoint the suspect brain area in people with Williams syndrome, a rare genetic disorder characterized by these behaviors.

21 Mar 2012

Fat-enclosed nanoparticles can directly irradiate brain tumor

For the past 40 years, radiation has been the most effective method for treating deadly brain tumors called glioblastomas. But, although the targeting technology has been refined, beams of radiation still must pass through healthy brain tissue to reach the tumor, and patients can only tolerate small amounts before developing serious side effects.

21 Mar 2012

Bone-marrow derived MSCs may reduce acute rejection rates in kidney recipients

Among patients with end-stage renal disease undergoing living-related kidney transplants, the use of bone-marrow derived mesenchymal (cells that can differentiate into a variety of cell types) stem cells instead of antibody induction therapy resulted in a lower incidence of acute rejection, decreased risk of opportunistic infection, and better estimated kidney function at 1 year, according to a study in the March 21 issue of JAMA.

21 Mar 2012

Two-year results from Boston Scientific's PROMUS Element trial to be presented at ACC 2012

Boston Scientific Corporation releases its schedule of product-related clinical research at the 61th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 24-27 in Chicago.

21 Mar 2012

MD Anderson, Transgenomic partner to evaluate use of ICE COLD-PCR

Transgenomic, Inc. today announced that it has begun a collaboration with The University of Texas MD Anderson Cancer Center to evaluate the use of the Company's very high sensitivity ICE COLD-PCR mutation detection technology in analysis of DNA isolated from circulating tumor cells (CTCs) in blood samples from patients with advanced cancer.

21 Mar 2012